Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study.

@article{GimnezArnau2007RupatadineIT,
  title={Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study.},
  author={A Gim{\'e}nez-Arnau and Ramon Maria Pujol and Simona Laura Ianoşi and Andrzej Kaszuba and Alejandro Malbr{\'a}n and G Poop and Esther Donado and I{\~n}aki P{\'e}rez and I. P{\'e}rez Izquierdo and Eva Arn{\'a}iz},
  journal={Allergy},
  year={2007},
  volume={62 5},
  pages={539-46}
}
BACKGROUND Chronic urticaria is one of the most common and disturbing cutaneous condition. The treatment of chronic idiopathic urticaria (CIU) is still a challenge. Antihistamines are recommended as first-line treatment. Rupatadine is a new potent nonsedative anti-H1. OBJECTIVE To study rupatadine efficacy and safety for moderate to severe CIU treatment. METHODS This randomized, double-blind, placebo-controlled, parallel-group, multicentre, study was designed to assess primarily mean… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.
30 Citations
30 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Similar Papers

Loading similar papers…